William Blair analyst Matt Phipps downgraded Evommune Inc (NYSE: EVMN) from Outperform to Market Perform.The analyst comments "Stock Thoughts: We ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE